Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Deloitte
Argus Health
Chubb
Citi
Healthtrust
Fuji
UBS

Generated: July 21, 2018

DrugPatentWatch Database Preview

Drugs in MeSH Category Sodium Channel Blockers

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc AMIODARONE HYDROCHLORIDE amiodarone hydrochloride INJECTABLE;INJECTION 203885-001 Nov 25, 2013 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gilead RANEXA ranolazine TABLET, EXTENDED RELEASE;ORAL 021526-001 Feb 12, 2007 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gilead RANEXA ranolazine TABLET, EXTENDED RELEASE;ORAL 021526-002 Jan 27, 2006 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Teva Pharms AMIODARONE HYDROCHLORIDE amiodarone hydrochloride TABLET;ORAL 074739-001 Nov 30, 1998 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Deloitte
Colorcon
UBS
US Army
Cipla
Healthtrust
Teva
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.